News for Healthier Living

Pancreatic Cancer Discovery Advances Toward First-of-Its-Kind Clinical Trial

Sylvester researchers identified IL1RAP as a key driver of pancreatic cancer treatment resistance. Backed by a V Foundation grant, the findings are advancing into a first-of-its-kind clinical trial combining IL1RAP-targeted therapy with chemoimmunotherapy before surgery.

June 23, 2026


June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026

June 16 2026

June 15 2026

June 14 2026

June 13 2026

June 12 2026

June 11 2026

June 10 2026